Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
799 Leser
Artikel bewerten:
(2)

KBC Groep: Koenraad Debackere succeeds Thomas Leysen as Chairman of the Board of Directors of KBC Group

Press Release
Outside trading hours - Regulated information* - Public disclosure of inside information

Brussels, 17 March 2020, 7.15 a.m. CET

Koenraad Debackere succeeds Thomas Leysen as Chairman of the Board of Directors of KBC Group

Mr Thomas Leysen announced on 21 June 2019 that he wished to end his mandates as Chairman of the Board of Directors of KBC Group, KBC Bank and KBC Insurance at the General Meeting of 7 May 2020. He's held those mandates since 2011.

The Board of Directors of KBC Group decided, unanimously and after careful consideration, and on the proposal of the nomination committee, to nominate Koenraad Debackere as successor to Thomas Leysen as Chairman of the Board of Directors of KBC Group, KBC Bank and KBC Insurance.

Koenraad Debackere is currently a non-executive director of KBC Group and KBC Insurance. The Board of Directors will propose to the General Meeting of 7 May 2020 that he be granted the status of independent director. The Board of Directors will then appoint him as Chairman of the Board of Directors of KBC Group, KBC Bank and KBC Insurance later this year when he will hand over his functions as managing director of the KU Leuven. In the meantime, and as of 7 May 2020, Philippe Vlerick, as vice-chairman of the KBC Group Board of Directors, will temporarily take over the chairmanship.

The appointment of Koenraad Debackere as non-executive director and chairman of the Board of Directors of KBC Group NV has been submitted to and approved by the National Bank of Belgium and the European Central Bank.

Thomas Leysen assumed the chairmanship of KBC Group in 2011 in the aftermath of the financial crisis and from that position guided the development of the KBC Group as an important and sustainable bank-insurer and asset manager in Belgium, Ireland and Central Europe. In recent years he has combined this position with the chairmanship of Umicore, Mediahuis and the King Baudouin Foundation.

Philippe Vlerick, Vice-Chairman of the KBC Group Boardof Directors thanks Thomas Leysen: "We are very grateful to Thomas Leysen for the decisive way in which he has chaired the Board of Directors of our group over the past 9 years. As a sparring partner of our CEO and the members of the Executive Committee, he was able to help shape KBC Group's strategic transformation, focusing on both the digitisation and sustainability of our group and its activities. Thomas was able to ensure the involvement of the Board of Directors in this transformation in an expert and balanced manner. Thomas Leysen has clearly contributed to a positive repositioning of KBC Group as a bank/insurer and reference in the different markets where the group is active and this to the great satisfaction and benefit of all stakeholders".

Thomas Leysen explained his decision as follows: "I am delighted to be able to pass on the torch to Koenraad Debackere. I am confident that the full Board of Directors, the Executive Committee and all stakeholders of KBC Group will feel supported by him. Thanks to his broad technological background and his many years of experience in innovation management, he is the right person to assist KBC in the digital transformation process that will determine KBC and the financial sector as a whole in the coming years. Koen is already familiar with KBC Group from his tenure as a non-executive director. Through his professional achievements, his broad knowledge of the economy and society, his international network and his personal charisma, he will also be able to provide valuable new insights, help shape KBC Group's long-term strategy and support the organisation on its way to profitable sustainable growth with a positive role in society".

Koenraad Debackere (°1961 in Ghent, Belgium) studied at the University of Ghent (Belgium) and MIT (Cambridge, USA). He obtained master and Ph.D. degrees in Electrical Engineering (M.Sc.) and Management Science & Business Administration (M.Sc. & Ph.D.).

He is a professor at the Faculty of Economics and Business Administration of KU Leuven. He has also held guest positions at various European universities and is currently managing director and board member of KU Leuven. He has held directorships at various technology companies, as well as at the investment funds Gemma Frisius Fonds NV, Essenscia Innovation Fund NV and LRM NV.

Koenraad Debackere is a non-executive director of KBC Group NV and KBC Verzekeringen.

For more information, please contact:

Viviane Huybrecht, General Manager, Corporate Communication/Spokesperson, KBC Group
Tel +32 2 429 85 45 - E-mail: pressofficekbc@kbc.be

* This news item contains information that is subject to the transparency regulations for listed companies.



KBC Group NV

Havenlaan 2 - 1080 Brussels



Viviane Huybrecht

General Manager

CorporateCommunication /Spokesperson

Tel. +32 2 429 85 45


Press Office

Tel. +32 2 429 65 01 Stef Leunens

Tel. +32 2 429 29 15 Ilse De Muyer

Tel. +32 2 429 32 88 Pieter Kussé



E-mail:pressofficekbc@kbc.be (mailto:pressofficekbc@kbc.be)


KBC press releases are available at www.kbc.com (http://www.kbc.com/) or can be obtained by sending an e-mail to pressofficekbc@kbc.be (mailto:pressofficekbc@kbc.be)

Follow us on www.twitter.com/kbc_group (http://www.twitter.com/kbc_group)
Stay up-to-date on all innovative solutions (https://www.kbc.com/en/newsroom/innovation/innovation-2020.html?zone=topnav)
Check this document's authenticity (https://www.kbc.be/particulieren/en/verifieer.html)

Attachment

  • 20200317_PB_VZ_ENG (https://ml-eu.globenewswire.com/Resource/Download/11b7aa76-ed96-4933-babd-1ff48a621d5a)
© 2020 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.